Daily Archives: January 6, 2009

A Conversation with the FDA About the Nature of REMS

  In 2007, the Food and Drug Administration Amendments Act (FDAAA) was signed into law by President Bush.  The legislation contained a great deal of reform of FDA regulation over the pharmaceutical and biotech industries, one element of which was … Continue reading

Posted in FDA Policy, Risk Management | 2 Comments